A Chance To Cut Is A Chance To Cure

  • Record Label: Matador
  • Release Date: Mar 13, 2001
Metascore
80

Generally favorable reviews - based on 13 Critics

Critic score distribution:
  1. Positive: 10 out of 13
  2. Negative: 0 out of 13
  1. To the duo's credit, Matmos avoids making A Chance to Cut Is a Chance to Cure grisly or gross; Andrew Daniel and Martin Schmidt approach the album's concept with their usual playfulness and an appropriately clinical detachment, resulting in some clever and surprisingly diverse songs
  2. The test of any conceptual record is how well it stands on its own, removed from the angle. And A Chance to Cut is a Chance to Cure is a first-rate work, even if you're unfamiliar with the backstory.
  3. 70
    An eminently listenable collage of jittery grooves, lop-sided beats and wayward electronica.
  4. 70
    Matmos have captured with discomforting vividness the sheer surrealism of the modern vanity industry, the medieval tortures people gladly endure in pursuit of physical perfection.
  5. Alternative Press
    80
    While A Chance may not move Matmos any closer to either the song or sound distinction, perhaps the fact that their music consistently provokes smiles and dark thought with increasing accessibility warrants our continued, if not increased, attention... [#154, p.76]
  6. Magnet
    80
    Some artists stimulate your brain, others tickle your senses. Matmos does both. [#50, p.101]
  7. The Wire
    90
    A splendid piece of work; compelling even when shorn of its conceptual and procedural backdrop, and infinitely more invigorating when considered as one with its making. [#205, p.58]
  8. Most [tracks] work quite well with the multifaceted rhythms and constantly evolving beats that make each of the tracks here a true expression of creativity.
  9. This is one concept album that doesn't forsake listenability for pure experimentation.
  10. A Chance to Cut Is a Chance to Cure is many things: inevitable, insane and their finest album.

Awards & Rankings

There are no user reviews yet.